A Study to Evaluate Efficacy, Safety and Tolerability of a Medication in Patients With Amyotrophic Lateral Sclerosis (ALS)

Purpose

The purpose of this study is to investigate a new therapy for the improvement of skeletal muscle function in conditions associated with muscle weakness or fatigue such as Amyotrophic Lateral Sclerosis (ALS). Participants will receive the study drug or a placebo.

Procedures

  • Approximately 7 study visits over 18 weeks
  • Participants will take a study drug or a placebo
  • Visits will consist of questionnaires, medical exams, muscle strength tests, blood draws, urine collection, an an electrocardiogram (ECG)

Eligibility

  • Diagnosis of ALS (Amyotrophic Lateral Sclerosis)

Age

18 to 65
65 and over

Gender

Male
Female

Monetary compensation

Yes

Can be done from home

No

Keywords

Amyotrophic lateral sclerosis (ALS), Neurology, Neuromuscular Disorders, Motor neuron disease, Lou Gehrig disease

Principal Investigator

James Wymer, MD

Department

Department of Neurology

Contact Information

rebecca.dettorre@neurology.ufl.edu

(352) 294-8948

Begin a new search for other research studies

Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams